< Back to situations

[ORGANIZATION]

GSK

Featured in 10 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [CH] [CN] [IT]

Sandoz biosimilar business expansion

2 clusters · 3 sources · last updated

Latest: Sandoz to invest USD 300 million in Slovenian biosimilar facility

Sandoz is expanding its biosimilar business through strategic partnerships and infrastructure investment. In August 2026, the company entered a $322 million collaboration with Shanghai Henlius Biotech to develop and comm

[QUIET] [HEALTH] [US]

Trump administration reforms childhood vaccine schedule

9 clusters · 358 sources · last updated

Latest: United States reduces universal childhood vaccine recommendations

In August 2026, the Trump administration overhauled the federal childhood vaccination schedule through an executive order titled ‘Delivering Gold Standard Childhood Vaccine Recommendations For Americans.’ Supported by He

[QUIET] [BUSINESS] [GB]

GSK corporate restructuring and financial performance

2 clusters · 2 sources · last updated

Latest: GSK faces long-term growth challenges despite recent profit boosts

GlaxoSmithKline (GSK) is undergoing significant structural and financial shifts. The company announced a £1.9 billion cost-cutting programme that includes a £400 million investment in UK life sciences. This plan involves

Also covered in